[Form 4] Taylor Morrison Home Corporation Insider Trading Activity

Rhea-AI Filing Summary

Curtis Vanhyfte, Chief Financial Officer of Taylor Morrison Home Corporation (TMHC), reported option exercises and a matched sale on 08/06/2025. He exercised employee stock options to acquire 1,501 shares at $26.28, 7,125 shares at $28.32 and 1,128 shares at $31.55, totaling 9,754 shares; the filing notes these options vested on 02/10/2024 and in two installments on 02/16/2024 and 02/16/2025.

On the same date he sold 9,754 shares at a weighted-average price of $65.22 (range $65.14–$65.48). Following these transactions the reporting person beneficially owned 14,163 shares.

Positive

• Options exercised: Acquired a total of 9,754 shares via employee stock options at exercise prices of $26.28, $28.32 and $31.55.
• Transparent pricing: Sale reported with a weighted-average price of $65.22 and a disclosed price range of $65.14–$65.48.
• Vesting disclosed: Filing notes vesting dates for the exercised options (02/10/2024 and installments on 02/16/2024 and 02/16/2025).

Negative

• Insider sale: Sold 9,754 shares on 08/06/2025, which reduced direct holdings.
• Reduced beneficial ownership: Reporting person’s holdings after the transactions are reported as 14,163 shares.

Insights

Financial Analyst

TL;DR: CFO exercised vested options and sold the resulting shares the same day, realizing proceeds at a ~$65.22 weighted-average price.

The filing shows option exercises that converted 9,754 vested option shares into common stock at exercise prices of $26.28, $28.32 and $31.55, followed by an immediate sale of those 9,754 shares at a weighted-average price of $65.22. This sequence is consistent with exercising and monetizing vested awards; the filing discloses the exact prices and the weighted-average sale range ($65.14–$65.48), and reports ending beneficial ownership of 14,163 shares. For investors, the transaction documents realization of intrinsic value from historic grants but does not, by itself, change outstanding share count or company financials.

Corporate Governance Expert

TL;DR: Disclosure is complete on face: vesting dates, exercise prices, sale prices and post-transaction holdings are reported.

The Form 4 includes required details: transaction date (08/06/2025), exercise prices and vesting notes, the weighted-average sale price and the numerical change in beneficial ownership. The explanatory footnotes specify the weighted-average sale price range and vesting schedule for the exercised options. From a governance and compliance perspective the form appears to meet Section 16 disclosure requirements by reporting exercises and subsequent sales and providing the requested explanatory information.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VANHYFTE CURTIS

(Last) (First) (Middle)

4900 N. SCOTTSDALE ROAD, SUITE 2000

(Street)

SCOTTSDALE AZ 85251

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Taylor Morrison Home Corp [ TMHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/06/2025		M		1,501	A	$26.28	15,664	D
Common Stock	08/06/2025		M		7,125	A	$28.32	22,789	D
Common Stock	08/06/2025		M		1,128	A	$31.55	23,917	D
Common Stock	08/06/2025		S		9,754	D	$65.22(1)	14,163	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to buy)	$26.28	08/06/2025		M			1,501	(2)	02/10/2030	Common Stock	1,501	$0	0	D
Employee Stock Option (Right to buy)	$28.32	08/06/2025		M			7,125	(3)	02/16/2031	Common Stock	7,125	$0	0	D
Employee Stock Option (Right to buy)	$31.55	08/06/2025		M			1,128	(3)	05/04/2031	Common Stock	1,128	$0	0	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.14 to $65.48, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of Taylor Morrison Home Corporation ("TMHC"), or to TMHC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

2. These options vested on February 10, 2024.

3. These options vested in two equal installments on each of February 16, 2024 and February 16, 2025.

	/s/ Todd Merrill, Attorney-in-Fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did TMHC CFO Curtis Vanhyfte report on 08/06/2025?

He exercised employee stock options to acquire 1,501, 7,125 and 1,128 shares (total 9,754) and sold 9,754 shares the same day.

At what prices were the options exercised and shares sold?

Exercise prices: $26.28, $28.32, $31.55. Sale weighted-average price: $65.22 (range $65.14–$65.48).

How many TMHC shares does the reporting person own after the transactions?

Beneficial ownership after transactions: 14,163 shares, as reported on the Form 4.

Were vesting dates disclosed for the exercised options?

Yes. One grant vested on 02/10/2024; the others vested in two equal installments on 02/16/2024 and 02/16/2025.

Who signed the Form 4 and when was it filed?

Signed by Todd Merrill, Attorney-in-Fact, and dated 08/08/2025 on the filing.